Emerging Infectious Disease ISSN: 1080-6059

Alcaligenes xylosoxidans Bloodstream Infections in Outpatient Oncology Office

Moon J. Kim*

, Elizabeth Bancroft*, Eleanor Lehnkering*, Rodney M. Donlan†, and Laurene Mascola*

Author affiliations: *Los Angeles County Department of Public Health, Los Angeles, California, USA; †Centers for Disease Control and Prevention, Atlanta, Georgia, USA;

Main Article

Figure 2

Pulsed-field gel electrophoresis of isolates from patients with Alcaligenes xylosoxidans bloodstream infection. Lane 1, laboratory standard; lanes 2 and 6, community strains of A. xylosoxidans; lanes 3–5 and 7–13, outbreak strains; lane 14, central venous catheter (CVC) port biofilm outbreak strain; lane 15, CVC port outbreak stain.

Figure 2. Pulsed-field gel electrophoresis of isolates from patients with Alcaligenes xylosoxidans bloodstream infection. Lane 1, laboratory standard; lanes 2 and 6, community strains of A. xylosoxidans; lanes 3–5 and 7–13, outbreak strains; lane 14, central venous catheter (CVC) port biofilm outbreak strain; lane 15, CVC port outbreak stain.

Main Article

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.